Lensar (LNSR) Long-Term Debt Issuances (2019 - 2020)

Lensar (LNSR) reported Long-Term Debt Issuances of $2.0 million for Q3 2020, down 72.97% quarter-over-quarter from $7.4 million in Q2 2020.

Lensar (LNSR) Long-Term Debt Issuances (2019 - 2020) Analysis & Trends

Lensar (LNSR) has 2 years of Long-Term Debt Issuances data on file, last reported at $2.0 million in Q3 2020.

Long-Term Debt Issuances for Q3 2020 came in at $2.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $12.4 million (changed N/A YoY), and the FY2020 annual result was $12.4 million, down 6.24% from the prior year.
Long-Term Debt Issuances declined to $2.0 million in Q3 2020 per LNSR's latest filing, from $7.4 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $9.0 million in Q4 2019 and troughed at $2.0 million in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	19.86 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	-
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	1.15 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	11.71 Mn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	-
10	Lensar	70.41 Mn	70.70 Mn	6.38 Mn	-

Download Data